- 全部删除
- 您的购物车当前为空
Grisnilimab(WT1)是一种靶向CD7的单克隆抗体。CD7在T细胞和T细胞/ B细胞相互作用中起重要作用,Wilms ' tumor 1 (WT1)基因在白血病和各种类型的实体瘤(如肺癌和结直肠癌)中过表达。
为众多的药物研发团队赋能,
让新药发现更简单!
Grisnilimab(WT1)是一种靶向CD7的单克隆抗体。CD7在T细胞和T细胞/ B细胞相互作用中起重要作用,Wilms ' tumor 1 (WT1)基因在白血病和各种类型的实体瘤(如肺癌和结直肠癌)中过表达。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,480 | In stock | |
5 mg | ¥ 7,880 | In stock | |
10 mg | ¥ 10,600 | In stock | |
25 mg | ¥ 15,700 | In stock | |
50 mg | ¥ 21,200 | In stock |
Grisnilimab 相关产品
产品描述 | Grisnilimab (WT1) is a monoclonal antibody targeting CD7. CD7 plays a crucial role in T cell and T cell/B cell interactions, and the Wilms' tumour 1 (WT1) gene is overexpressed in leukaemia and various types of solid tumours (such as lung cancer and colorectal cancer). |
别名 | WT1, WT 1 |
CAS No. | 2367001-70-3 |
存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容